These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10834825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK, Fernandes Ode F, Kobayashi CC, Passos XS, Costa CR, Lemos JA, Souza-Júnior AH, Silva Mdo R.
    Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
    Nguyen MH, Yu CY.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):471-2. PubMed ID: 9527812
    [Abstract] [Full Text] [Related]

  • 5. DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
    Morera-López Y, Torres-Rodríguez JM, Jiménez-Cabello T, Baró-Tomás T, Alía-Aponte C, Lázera MS.
    Mycopathologia; 2005 Aug; 160(1):9-14. PubMed ID: 16160762
    [Abstract] [Full Text] [Related]

  • 6. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR.
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil.
    Soares MC, Paula CR, Dias AL, Caseiro MM, Costa SO.
    Rev Inst Med Trop Sao Paulo; 2005 Jan; 47(1):31-6. PubMed ID: 15729472
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
    Perfect JR, Cox GM, Dodge RK, Schell WA.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence and antifungal susceptibility of Cryptococcus neoformans isolated from pigeon excreta in Chon Buri Province, Eastern Thailand.
    Tangwattanachuleeporn M, Somparn P, Poolpol K, Gross U, Weig M, Bader O.
    Med Mycol J; 2013 Aug; 54(3):303-7. PubMed ID: 23995421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isolation of Cryptococcus neoformans var. neoformans from pigeon droppings collected throughout Turkey.
    Yildiran ST, Saracli MA, Gönlüm A, Gün H.
    Med Mycol; 1998 Dec; 36(6):391-4. PubMed ID: 10206749
    [Abstract] [Full Text] [Related]

  • 16. In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
    Illnait-Zaragozi MT, Martínez GF, Curfs-Breuker I, Fernández CM, Boekhout T, Meis JF.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1580-2. PubMed ID: 18212095
    [Abstract] [Full Text] [Related]

  • 17. In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans.
    Hossain MA, Maesaki S, Mitsutake K, Kakeya H, Sasaki E, Tomono K, Tashiro T, Kohno S.
    J Antimicrob Chemother; 1999 Dec; 44(6):827-9. PubMed ID: 10590286
    [Abstract] [Full Text] [Related]

  • 18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 19. In Vitro Antifungal Susceptibility of Environmental Isolates of Cryptococcus spp. from the West Region of Cameroon.
    Dongmo W, Kechia F, Tchuenguem R, Nangwat C, Yves I, Kuiate JR, Dzoyem JP.
    Ethiop J Health Sci; 2016 Nov; 26(6):555-560. PubMed ID: 28450771
    [Abstract] [Full Text] [Related]

  • 20. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
    Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I, Kwon-Chung KJ.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1856-61. PubMed ID: 10428902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.